litlas
ログインアカウント作成

Yue Xiong

1988–2025 年に発表

202
論文数
42,410
被引用数
105
h 指数
182
i10 指数

被引用数

Yue Xiong の年別被引用数1987 年: 被引用 1 件1988 年: 被引用 3 件1989 年: 被引用 6 件1990 年: 被引用 18 件1991 年: 被引用 32 件1992 年: 被引用 67 件1993 年: 被引用 154 件1994 年: 被引用 270 件1995 年: 被引用 334 件1996 年: 被引用 305 件1997 年: 被引用 286 件1998 年: 被引用 291 件1999 年: 被引用 435 件2000 年: 被引用 375 件2001 年: 被引用 309 件2002 年: 被引用 269 件2003 年: 被引用 248 件2004 年: 被引用 275 件2005 年: 被引用 256 件2006 年: 被引用 264 件2007 年: 被引用 230 件2008 年: 被引用 241 件2009 年: 被引用 254 件2010 年: 被引用 291 件2011 年: 被引用 361 件2012 年: 被引用 406 件2013 年: 被引用 445 件2014 年: 被引用 474 件2015 年: 被引用 493 件2016 年: 被引用 450 件2017 年: 被引用 466 件2018 年: 被引用 449 件2019 年: 被引用 1,183 件2020 年: 被引用 1,436 件2021 年: 被引用 1,410 件2022 年: 被引用 1,270 件2023 年: 被引用 1,095 件2024 年: 被引用 1,600 件2025 年: 被引用 810 件2026 年: 被引用 17 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,215 件、この内訳の 32.3%中国: 引用元論文 3,864 件、この内訳の 20%イギリス: 引用元論文 975 件、この内訳の 5.1%ドイツ: 引用元論文 885 件、この内訳の 4.6%日本: 引用元論文 705 件、この内訳の 3.7%フランス: 引用元論文 584 件、この内訳の 3%カナダ: 引用元論文 563 件、この内訳の 2.9%イタリア: 引用元論文 530 件、この内訳の 2.7%韓国: 引用元論文 359 件、この内訳の 1.9%スペイン: 引用元論文 335 件、この内訳の 1.7%オーストラリア: 引用元論文 321 件、この内訳の 1.7%インド: 引用元論文 321 件、この内訳の 1.7%
0%32.3%その他 18.7%

機関

分野

  • Biochemistry, Genetics and Molecular Biology51.2%
  • Medicine37.9%
  • Immunology and Microbiology3.9%
  • Agricultural and Biological Sciences3.1%
  • Neuroscience1.4%
  • Chemistry0.4%
  • その他2.1%

トピック

  • Cancer-related Molecular Pathways5.9%
  • Epigenetics and DNA Methylation5.2%
  • Ubiquitin and proteasome pathways4.9%
  • Cancer, Hypoxia, and Metabolism4.2%
  • RNA modifications and cancer2.9%
  • Hippo pathway signaling and YAP/TAZ2%
  • その他74.9%

共著者

全論文

検索で開く
  1. Advancing targeted protein degradation for cancer therapy

    著者: Brandon Dale, Meng Cheng, Kwang‐Su Park, H. Ümit Kanıskan, Yue Xiong, Jian Jin - Nature reviews. Cancer 2021 被引用: 611

  2. Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

    著者: Wei Xu, Hui Yang, Ying Liu, Ying Yang, Ping Wang, Se Hee Kim, Shinsuke Ito, Yang Chen, Pu Wang, Meng-Tao Xiao, Li-xia Liu, Wen-qing Jiang, Jing Liu, Jin-ye Zhang, Bin Wang, Stephen V. Frye, Yi Zhang, Yan-hui Xu, Qun‐Ying Lei, Kun‐Liang Guan, Shimin Zhao, Yue Xiong - Cancer Cell 2011 被引用: 2,849

  3. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

    著者: Mengtao Xiao, Hui Yang, Wei Xu, Shenghong Ma, Huaipeng Lin, Honguang Zhu, Lixia Liu, Ying Liu, Yang Chen, Yanhui Xu, Shimin Zhao, Dan Ye, Yue Xiong, Kun‐Liang Guan - Genes & Development 2012 被引用: 1,132

  4. Targeting ferroptosis alleviates methionine‐choline deficient (MCD)‐diet induced NASH by suppressing liver lipotoxicity

    著者: Xiaoya Li, Tianxiang Wang, Xinmei Huang, Yue Li, Tiange Sun, Shufei Zang, Kun‐Liang Guan, Yue Xiong, Jun Liu, Hai‐Xin Yuan - Liver International 2020 被引用: 277

  5. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy

    著者: Yujia Chen, Guan-Nan Li, Xian-Jing Li, Lin-Xing Wei, Minjie Fu, Zhou‐Li Cheng, Zhen Yang, Gui‐Qi Zhu, Xudong Wang, Cheng Zhang, Jinye Zhang, Yiping Sun, Hexige Saiyin, Jin Zhang, Wei‐Ren Liu, Wenwei Zhu, Kun‐Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Leilei Chen - Science Advances 2023 被引用: 143

  6. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses

    著者: Leilei Chen, Carmen Morcelle, Zhou‐Li Cheng, Xiufei Chen, Yanping Xu, Yajing Gao, Junbin Song, Zhijun Li, Matthew D. Smith, Miao Shi, Yezhang Zhu, Neng Zhou, Meng Cheng, Chenxi He, Kwei‐Yan Liu, Guoping Lü, Lei Zhang, Cheng Zhang, Jinye Zhang, Yiping Sun, Tuan Qi, Yingying Lyu, Zhizhong Ren, Xianming Tan, Jiayong Yin, Fei Lan, Ying Liu, Hui Yang, Maoxiang Qian, Cai‐Wen Duan, Xing Chang, Yufeng Zhou, Li Shen, Albert S. Baldwin, Kun‐Liang Guan, Yue Xiong, Dan Ye - Nature Cell Biology 2022 被引用: 206

  7. Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets

    著者: Yan Xiong, Yue Zhong, Hyerin Yim, Xiaobao Yang, Kwang‐Su Park, Ling Xie, Poulikos I. Poulikakos, Xiaoran Han, Yue Xiong, Xian Chen, Jing Liu, Jian Jin - Journal of the American Chemical Society 2022 被引用: 129

  8. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer

    著者: Xiufei Chen, Meng‐Xin Tian, Renqiang Sun, Mengli Zhang, Lisha Zhou, Lei Jin, Lei‐Lei Chen, Wen‐Jie Zhou, Kun‐Long Duan, Yu‐Jia Chen, Chao Gao, Zhou‐Li Cheng, Fang Wang, Jinye Zhang, Yi‐Ping Sun, Hongxiu Yu, Yuzheng Zhao, Yi Yang, Weiren Liu, Ying–Hong Shi, Yue Xiong, Kun‐Liang Guan, Dan Ye - EMBO Reports 2018 被引用: 281

  9. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis

    著者: Renqiang Sun, Zhiyong Zhang, Ruoxuan Bao, Xiaozhen Guo, Yuan Gu, Wenjing Yang, Jinsong Wei, Xinyu Chen, Lingfeng Tong, Jianping Meng, Chen Zhong, Cheng Zhang, Jinye Zhang, Yiping Sun, Chen Ling, Xuemei Tong, Fa‐Xing Yu, Hongxiu Yu, Wei‐Feng Qu, Bing Zhao, Wei Guo, Maoxiang Qian, Hexige Saiyin, Ying Liu, Ronghua Liu, Cen Xie, Weiren Liu, Yue Xiong, Kun‐Liang Guan, Ying–Hong Shi, Pu Wang, Dan Ye - Journal of Hepatology 2022 被引用: 188

  10. Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation through Chaperone-Mediated Autophagy and Promotes Tumor Growth

    著者: Lei Lv, Li Dong, Di Zhao, Ruiting Lin, Yajing Chu, Heng Zhang, Zhengyu Zha, Ying Liu, Zi Li, Yanping Xu, Gang Wang, Yong Huang, Yue Xiong, Kun‐Liang Guan, Qun‐Ying Lei - Molecular Cell 2011 被引用: 599

  11. Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy

    著者: Yanping Xu, Lei Lv, Ying Liu, Matthew D. Smith, Wencai Li, Xianming Tan, Meng Cheng, Zhijun Li, Michael Bovino, Jeffrey Aubé, Yue Xiong - Journal of Clinical Investigation 2019 被引用: 226

  12. TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway

    著者: Qun‐Ying Lei, Heng Zhang, Bin Zhao, Zhengyu Zha, Feng Bai, Xin‐Hai Pei, Shimin Zhao, Yue Xiong, Kun‐Liang Guan - Molecular and Cellular Biology 2008 被引用: 922

  13. Mitogenic and Oncogenic Stimulation of K433 Acetylation Promotes PKM2 Protein Kinase Activity and Nuclear Localization

    著者: Lei Lv, Yan-Ping Xu, Di Zhao, Fu-Long Li, Wei Wang, Naoya Sasaki, Ying Jiang, Xin Zhou, Ting-Ting Li, Kun‐Liang Guan, Qun‐Ying Lei, Yue Xiong - Molecular Cell 2013 被引用: 332

  14. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS

    著者: Jinye Zhang, Kun‐Liang Guan, Yaohui Chen, Shimin Zhao, Qun‐Ying Lei, Yue Xiong, Yan Lin - EMBO Reports 2011 被引用: 552

  15. BTB Protein Keap1 Targets Antioxidant Transcription Factor Nrf2 for Ubiquitination by the Cullin 3-Roc1 Ligase

    著者: Manabu Furukawa, Yue Xiong - Molecular and Cellular Biology 2004 被引用: 733

  16. TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition

    著者: Qun‐Ying Lei, Kun‐Liang Guan, Heng Zhang, Bin Zhao, Yue Xiong, Jun Yao, Chen Ying Liu, Shimin Zhao, Zheng Zha - Journal of Biological Chemistry 2009 被引用: 568

  17. Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer

    著者: Ping Wang, Yue Xiong, Qun‐Ying Lei, Kun‐Liang Guan, Ying Liu, Xin Zhou, Yan Hui Xu, Di Zhao, Yan Mo, Shao Wu Zou, Bo Dong - Cancer Cell 2013 被引用: 342

  18. Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder

    著者: Yue Xiong, Jianhui Chen, Yingbo Li - Frontiers in Neuroscience 2023 被引用: 95

  19. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

    著者: Shimin Zhao, Yan Lin, Wei Xu, Wenqing Jiang, Zhengyu Zha, Pu Wang, Wei Yu, Zhiqiang Li, Ling-Ling Gong, Yingjie Peng, Jianping Ding, Qun‐Ying Lei, Kun‐Liang Guan, Yue Xiong - Science 2009 被引用: 1,110

  20. IDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives

    著者: Hui Yang, Dan Ye, Kun‐Liang Guan, Yue Xiong - Clinical Cancer Research 2012 被引用: 432

  21. SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense

    著者: Yue Xiong, Dan Ye, Renqiang Sun, Xiufei Chen, Shiwen Wang, Kun‐Liang Guan, Hongxiu Yu, Yi Wang, Fang Wang, Qi Xu, Mengli Zhang, Lisha Zhou, Pengyuan Yang - EMBO Reports 2016 被引用: 297

  22. Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders

    著者: Meng Cheng, Xufen Yu, Kaylene Lu, Ling Xie, Li Wang, Fanye Meng, Xiaoran Han, Xian Chen, Jing Liu, Yue Xiong, Jian Jin - Journal of Medicinal Chemistry 2020 被引用: 181

  23. Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication

    著者: Christopher M. Murphy, Yanping Xu, Feng Li, Kouki Nio, Natalia Reszka-Blanco, Xiaodong Li, Yaxu Wu, Yanbao Yu, Yue Xiong, Lishan Su - Cell Reports 2016 被引用: 317

  24. The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase

    著者: Chen‐Ying Liu, Zhengyu Zha, Xin Zhou, Heng Zhang, Wei Huang, Di Zhao, Tingting Li, Siew Wee Chan, Chun Jye Lim, Wanjin Hong, Shimin Zhao, Yue Xiong, Qun‐Ying Lei, Kun‐Liang Guan - Journal of Biological Chemistry 2010 被引用: 519